| PUBCHEM ID |
73050795
|
| UNII |
6B7BK5H33B
|
| Preferred Term |
TETRACYCLINE PHOSPHATE COMPLEX
|
| CAS |
1336-20-5
|
| INCHIKEY |
DKNFPOTZPZOJHC-LBTQIPEASA-M
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C[C@@]([C@H](C[C@H]([C@H](C(O)=C(C(N)=O)C1=O)N(C)C)[C@@]11O)C2=C1O)(c1cccc(O)c1C2=O)O
|
| Total Surface Area |
291,28
|
| Relative PSA |
0,42378
|
| TPSA |
181,62
|
| cLogS |
-1,829
|
| MW |
444,439
|
| cLogP |
-1,3318
|
| H-Acceptors |
10
|
| H-Donors |
6
|
| Ro5 violations |
1
|
| Druglikeness |
5,2428
|
| DrugScore |
0,810805492315463
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
0,7655
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,7788
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5805
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,7095
|
| Carcinogenicity (Three-class) |
Non-required
|
